CareDx Q3 Adj EPS $(0.18) Beats $(0.39) Estimate, Sales $67.19M Beat $53.14M Estimate
Portfolio Pulse from totan@benzinga.com
CareDx reported Q3 losses of $(0.18) per share, beating the analyst consensus estimate of $(0.39) by 53.85%. The company also reported quarterly sales of $67.19 million, beating the analyst consensus estimate of $53.14 million by 26.44%. However, this represents a 200% increase in losses and a 15.33% decrease in sales compared to the same period last year.
November 08, 2023 | 9:32 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
CareDx reported better than expected Q3 results but with increased losses and decreased sales YoY.
While CareDx beat estimates, the increased losses and decreased sales compared to the same period last year could potentially offset any positive impact from beating estimates.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100